CoChat

Design and Synthesis of 4-Azaindoles as Inhibitors of p38 MAP Kinase

Open access
Trejo, Alejandra, Arzeno, Humberto, Browner, Michelle, Chanda, Sushmita, Cheng, Soan, Comer, Daniel D., Dalrymple, Stacie A., Dunten, Pete, Lafargue, JoAnn, Lovejoy, Brett, Freire-Moar, Jose, Lim, Julie, Mcintosh, Joel, Miller, Jennifer, Papp, Eva, Reuter, Deborah, Roberts, Rick, Sanpablo, Florentino, Saunders, John, Song, Kyung, Villasenor, Armando, Warren, Stephen D., Welch, Mary, Weller, Paul, Whiteley, Phyllis E., Zeng, Lu, Goldstein, David M. · 2003 · Journal of Medicinal Chemistry
Cited by 96

The DOI matches its Crossref record.

Abstract

Inhibition of the biosynthesis of proinflammatory cytokines such as tumor necrosis factor and interleukin-1 via p38 has been an approach toward the development of a disease modifying agent for the treatment of chronic inflammation and autoimmune diseases. The development of a new core structure of p38 inhibitors, 3-(4-fluorophenyl)-2-(pyridin-4-yl)-1H-pyrrolo[3,2-b] pyridine, is described. X-ray crystallographic data of the lead bound to the active site of p38 was used to guide the optimization of the series. Specific focus was placed on modulating the physical properties of the core while maintaining potent inhibition of p38. These efforts identified 42c as a potent inhibitor of p38, which also possessed the required physical properties worthy of advanced studies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/jm0301787

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

Metadata

Authors
Trejo, A., Arzeno, H., Browner, M., Chanda, S., Cheng, S., Comer, D. D., Dalrymple, S. A., Dunten, P., Lafargue, J., Lovejoy, B., Freire-Moar, J., Lim, J., Mcintosh, J., Miller, J., Papp, E., Reuter, D., Roberts, R., Sanpablo, F., Saunders, J., Song, K., Villasenor, A., Warren, S. D., Welch, M., Weller, P., Whiteley, P. E., Zeng, L., & Goldstein, D. M.
Venue
Journal of Medicinal Chemistry
Published
2003-09-19
Volume
46
Issue
22
Pages
4702-4713
ISSN
  • 0022-2623 (ISSN-L)
  • 1520-4804
OpenAlex
W2085146176
Cited by
96
References
0
FWCI
2.35
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.